Chester County News and Community Website
RADNOR, PA — NRx Pharmaceuticals (NRx) (NASDAQ: NRXP) recently provided a safety update on ZYESAMI™ (aviptadil) which is being tested in the ACTIV-3 Critical Care Phase 3 study sponsored by the National …
Read More
DOYLESTOWN, PA — Evrys Bio has been awarded a $34.3 million contract from the Department of Defense (DOD) to develop a drug, simultaneously effective against multiple high-risk viral agents.
Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) announced it has received authorization from the U.S. Food and Drug Administration to proceed with its Investigational New Drug (IND) application for …
Read More RADNOR, PA — NRx Pharmaceuticals (Nasdaq: NRXP) (NRx), a clinical stage pharmaceutical company, today announced it has filed an application with U.S. Food and Drug Administration (FDA) requesting Emergency Use …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy sotrovimab for the treatment of mild-to-moderate COVID-19 in adults …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the …
Read More
WASHINGTON. D.C. — U.S. Department of Veterans Affairs (VA) researchers and Veteran volunteers from the Atlanta and San Antonio VA medical centers were part of a recently published study that yielded crucial …
Read More
WASHINGTON, D.C. — A web-based COVID-19 outpatient treatment locator maintained by the U.S. Department of Health and Human Services (HHS) is now available to assist healthcare providers and patients in finding potential …
Read More
HARRISBURG, PA — Pennsylvania Treasurer Joe Torsella this week co-filed a shareholder proposal at Gilead, maker of remdesivir (brand name: Veklury), the only antiviral drug approved by the Food and …
Read More